CaseBioscience specializes in the development and manufacturing of advanced sterile media products tailored for cell and gene therapy (CGT) and assisted reproductive technology (ART). Their flagship products include CaseCryo® NON-DMSO and DMSO formulations, which are designed for the cryopreservation of human pluripotent stem cells and other cell types. These innovative cryopreservation media are engineered to enhance cell viability and functionality, addressing the limitations of traditional DMSO-based solutions. The company emphasizes the importance of quality and safety, adhering to stringent cGMP standards and ISO certifications to ensure that their products meet the rigorous demands of preclinical and clinical applications.

In addition to cryopreservation solutions, CaseBioscience is committed to advancing culture media for stem cell metabolism and embryo culture. By integrating expertise from both ART and CGT, they are developing next-generation media that optimize cell survival and performance. Their focus on chemically defined, animal-free formulations with low endotoxin levels aims to improve outcomes in both fields. The company’s dedication to innovation and quality positions it as a leader in the biotechnology sector, facilitating advancements in regenerative medicine and enhancing the efficacy of cell therapies.

United States

We are an ISO 13485:2016 Certified Manufacturer developing innovative media formulations for cell cryopreservation, cell culture, and cell handling in cell therapy, gene therapy, and regenerative medicine. We deliver high-quality products with batch-to-batch consistency and rigorous quality controls from raw materials to final product release. We offer manufacturing services, scientific assistance in media formulation, and optimization of existing formulations to meet your specific needs.

CaseBioscience

Company Details